BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7082687)

  • 21. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
    Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
    Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Structural bases of thrombin specificity. Role of secondary interactions].
    Kibirev VK; Romanova VP; Serebrianyĭ SB
    Biokhimiia; 1983 Jun; 48(6):937-43. PubMed ID: 6882831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides.
    Isetti G; Maurer MC
    Biochemistry; 2004 Apr; 43(14):4150-9. PubMed ID: 15065858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct determination of the substrate specificity of the alpha-active site in heterodimeric beta-hexosaminidase A.
    Hou Y; Tse R; Mahuran DJ
    Biochemistry; 1996 Apr; 35(13):3963-9. PubMed ID: 8672428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [pH-dependence of the esterolytic activity of terrylytine proteases].
    Bol'shakova MD; Selezneva AA; Tereshin IM
    Biokhimiia; 1980 Oct; 45(10):1740-3. PubMed ID: 6165400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Inhibition of the proteolytic activity of thrombin by methyl esters of arginine-containing oligopeptides].
    Poiarkova SA; Kibirev NK; Serebrianyĭ SB
    Ukr Biokhim Zh (1978); 1986; 58(6):3-8. PubMed ID: 3798577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. N-ethoxycarbonyl-D-phenylalanyl-L-prolyl-alpha-azalysine p-nitrophenyl ester: a novel, high selective and optimal chromogenic active site titrant for human and bovine alpha-, beta- and gamma-thrombin.
    Balliano G; Milla P; Giordano C; Gallina C; Coletta M; Menegatti E; Rizzi M; Bolognesi M; Ascenzi P
    Biochem Biophys Res Commun; 1996 Aug; 225(2):557-61. PubMed ID: 8753800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the P2' and P3' specificities of thrombin using fluorescence-quenched substrates and mapping of the subsites by mutagenesis.
    Le Bonniec BF; Myles T; Johnson T; Knight CG; Tapparelli C; Stone SR
    Biochemistry; 1996 Jun; 35(22):7114-22. PubMed ID: 8679538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and kinetic characterisation of omega-guanidinocarbonic acid ethyl esters as trypsin substrates.
    Schuster M; Medvedkin VN; Schellenberger V; Mitin YuV ; Jakubke HD
    Biomed Biochim Acta; 1990; 49(6):519-21. PubMed ID: 2275728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of the relationship between the reactivity of synthetic substrates and thrombin inhibitors and their structure].
    Kibirev VK; Gershkovich AA; Serebrianyĭ SB
    Ukr Biokhim Zh (1978); 1983; 55(3):271-6. PubMed ID: 6868150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Kininogenase activity of alpha and beta/gamma forms of bovine thrombin].
    Egorova TP; Strukova SM; Kireeva EG
    Biokhimiia; 1984 Feb; 49(2):328-33. PubMed ID: 6561967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thrombin specificity.
    Guillin MC; Bezeaud A; Bouton MC; Jandrot-Perrus M
    Thromb Haemost; 1995 Jul; 74(1):129-33. PubMed ID: 8578445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities.
    Sonder SA; Fenton JW
    Clin Chem; 1986 Jun; 32(6):934-7. PubMed ID: 3708816
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The methyl group of N(alpha)(Me)Arg-containing peptides disturbs the active-site geometry of thrombin, impairing efficient cleavage.
    Friedrich R; Steinmetzer T; Huber R; Stürzebecher J; Bode W
    J Mol Biol; 2002 Mar; 316(4):869-74. PubMed ID: 11884127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction.
    Gorman JJ
    Biochim Biophys Acta; 1975 Dec; 412(2):273-82. PubMed ID: 1191680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human alpha-thrombin inhibition by the highly selective compounds N-ethoxycarbonyl-D-Phe-Pro-alpha-azaLys p-nitrophenyl ester and N-carbobenzoxy-Pro-alpha-azaLys p-nitrophenyl ester: a kinetic, thermodynamic and X-ray crystallographic study.
    De Simone G; Balliano G; Milla P; Gallina C; Giordano C; Tarricone C; Rizzi M; Bolognesi M; Ascenzi P
    J Mol Biol; 1997 Jun; 269(4):558-69. PubMed ID: 9217260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic esters recognized by glucuronoyl esterase from Schizophyllum commune.
    Spániková S; Poláková M; Joniak D; Hirsch J; Biely P
    Arch Microbiol; 2007 Aug; 188(2):185-9. PubMed ID: 17440709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the active site for hydrolysis of aryl amides and choline esters by human cholinesterases.
    Darvesh S; McDonald RS; Darvesh KV; Mataija D; Mothana S; Cook H; Carneiro KM; Richard N; Walsh R; Martin E
    Bioorg Med Chem; 2006 Jul; 14(13):4586-99. PubMed ID: 16504521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of functional domains within the alpha and beta subunits of beta-hexosaminidase A through the expression of alpha-beta fusion proteins.
    Tse R; Wu YJ; Vavougios G; Hou Y; Hinek A; Mahuran DJ
    Biochemistry; 1996 Aug; 35(33):10894-903. PubMed ID: 8718882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies.
    Monteiro RQ; Campana PT; Melo PA; Bianconi ML
    Int J Biochem Cell Biol; 2004 Oct; 36(10):2077-85. PubMed ID: 15203120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.